Header Logo

Connection

LAYLA ABUSHAMAT to Fatty Liver

Back to Details
This is a "connection" page, showing publications LAYLA ABUSHAMAT has written about Fatty Liver.
LAYLA ABUSHAMAT
Connection Strength
0.201
Fatty Liver
  1. The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis. Clin Gastroenterol Hepatol. 2024 Aug; 22(8):1565-1574.
    View in: PubMed
    Score: 0.201
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.